Data as of Aug 29
| +0.72 / +1.11%|
The 22 analysts offering 12-month price forecasts for St. Jude Medical Inc have a median target of 75.00, with a high estimate of 81.00 and a low estimate of 51.00. The median estimate represents a +14.35% increase from the last price of 65.59.
The current consensus among 27 polled investment analysts is to Buy stock in St. Jude Medical Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.